Anderson CJ - Search Results

1

Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.

Nedrow JR, Latoche JD, Day KE, Modi J, Ganguly T, Zeng D, Kurland BF, Berkman CE, Anderson CJ. Nedrow JR, et al. Among authors: anderson cj. Mol Imaging Biol. 2016 Jun;18(3):402-10. doi: 10.1007/s11307-015-0908-7. Mol Imaging Biol. 2016. PMID: 26552656

2

A potential Dubin-Johnson syndrome imaging agent: synthesis, biodistribution, and microPET imaging.

Yoo J, Reichert DE, Kim J, Anderson CJ, Welch MJ. Yoo J, et al. Among authors: anderson cj. Mol Imaging. 2005 Jan-Mar;4(1):18-29. doi: 10.1162/15353500200504160. Mol Imaging. 2005. PMID: 15967123

3

Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells.

Parry JJ, Eiblmaier M, Andrews R, Meyer LA, Higashikubo R, Anderson CJ, Rogers BE. Parry JJ, et al. Among authors: anderson cj. Mol Imaging. 2007 Jan-Feb;6(1):56-67. Mol Imaging. 2007. PMID: 17311765

4

Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging.

Anderson CJ, Wadas TJ, Wong EH, Weisman GR. Anderson CJ, et al. Q J Nucl Med Mol Imaging. 2008 Jun;52(2):185-92. Epub 2007 Nov 28. Q J Nucl Med Mol Imaging. 2008. PMID: 18043536 Free PMC article. Review.

5

Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.

Lewis JS, Anderson CJ. Lewis JS, et al. Among authors: anderson cj. Methods Mol Biol. 2007;386:227-40. doi: 10.1007/978-1-59745-430-8_8. Methods Mol Biol. 2007. PMID: 18604948 Review.

6

Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

Anderson CJ, Ferdani R. Anderson CJ, et al. Cancer Biother Radiopharm. 2009 Aug;24(4):379-93. doi: 10.1089/cbr.2009.0674. Cancer Biother Radiopharm. 2009. PMID: 19694573 Free PMC article.

7

Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation.

Zheleznyak A, Wadas TJ, Sherman CD, Wilson JM, Kostenuik PJ, Weilbaecher KN, Anderson CJ. Zheleznyak A, et al. Among authors: anderson cj. Mol Imaging Biol. 2012 Aug;14(4):500-8. doi: 10.1007/s11307-011-0512-4. Mol Imaging Biol. 2012. PMID: 21853370 Free PMC article.

8

Rapid and sensitive LC-MS approach to quantify non-radioactive transition metal impurities in metal radionuclides.

Zeng D, Anderson CJ. Zeng D, et al. Among authors: anderson cj. Chem Commun (Camb). 2013 Apr 4;49(26):2697-9. doi: 10.1039/c3cc39071c. Chem Commun (Camb). 2013. PMID: 23435511

9

The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals.

Zeng D, Zeglis BM, Lewis JS, Anderson CJ. Zeng D, et al. Among authors: anderson cj. J Nucl Med. 2013 Jun;54(6):829-32. doi: 10.2967/jnumed.112.115550. Epub 2013 Apr 24. J Nucl Med. 2013. PMID: 23616581 Free PMC article. Review.

10

New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides.

Zeng D, Ouyang Q, Cai Z, Xie XQ, Anderson CJ. Zeng D, et al. Among authors: anderson cj. Chem Commun (Camb). 2014 Jan 4;50(1):43-5. doi: 10.1039/c3cc45928d. Chem Commun (Camb). 2014. PMID: 24141371 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters